
Quintiles Advances Risk-based Monitoring with the Launch of Data-driven Trial Execution Powered by Infosario Clinical
New offering improves the quality and predictability of clinical development while reducing overall trial costs by up to 25 percent
“Our customers are seeking to manage clinical trials with greater efficiency, seamless execution and predictive insights that enable them to respond faster and make better-informed decisions,” said Paula Brown Stafford, president of Clinical Development at Quintiles. “Data-driven Trial Execution is the first in a series of standardized offerings that Quintiles plans to bring to market, and is our answer to optimized trial execution that has the potential to improve quality while reducing overall trial costs by up to 25 percent.”
Quintiles is an industry leader in
Data-driven Trial Execution is powered by enhancements to the award-winning
For more information on Data-driven Trial Execution, please visit
Related to this article







